Blockchain Registration Transaction Record

GeoVax Announces Q2 2025 Financial Results and Corporate Update

GeoVax Labs to discuss Q2 2025 financial results and corporate updates, highlighting advancements in vaccines for COVID-19 and cancer therapies. Join the live webcast.

GeoVax Announces Q2 2025 Financial Results and Corporate Update

GeoVax's upcoming financial results and corporate update are significant for investors and the healthcare sector, as the company is pioneering vaccines and therapies for critical health challenges, including COVID-19 and cancer. Their progress in clinical trials could lead to breakthroughs in treatment options for immunocompromised patients and those with solid tumors, marking a potential turning point in how these conditions are managed.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x82f2efc2b22cb4a7108a1b24b619264b1010fac07a1fa3e6454c1fa71edf3bf4
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintkiwiCARN-8ec6865be0e320696edeb4f9f33ce3a6